Contact Us

No Form
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



   * Please describe your case:

Date of Incident : 

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Pfizer Reaches Settlement In Lawsuit

Jul 3, 2004 | UPI Pfizer Inc. has reached a $60 million settlement in an Illinois class-action case that accused the firm of falsely marketing its diabetes drug Rezulin.

The two-year-old lawsuit accused the Warner-Lambert Co., which Pfizer bought in June 2000, of misrepresenting Rezulin's safety between 1996 and March 2000 when it stopped selling Rezulin, the St. Louis Post-Dispatch reported Saturday.

The suit alleged the drug caused liver problems in 5 percent of the people who used it, contradicting advertising about Rezulin's "unparalleled safety."

The preliminary settlement, under which Pfizer did not admit wrongdoing, was approved in May, but sealed until Friday.

The settlement calls for all current Illinois residents who bought Rezulin to recoup up to 85 percent of their out-of-pocket costs for the drug. Class members must prove they were prescribed Rezulin and provide documentation of how much they spent for the drug.

Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo